Daolin Ji

968 total citations
19 papers, 554 citations indexed

About

Daolin Ji is a scholar working on Cancer Research, Molecular Biology and Surgery. According to data from OpenAlex, Daolin Ji has authored 19 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 15 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Daolin Ji's work include Cancer-related molecular mechanisms research (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and RNA modifications and cancer (8 papers). Daolin Ji is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers) and RNA modifications and cancer (8 papers). Daolin Ji collaborates with scholars based in China, Hong Kong and Germany. Daolin Ji's co-authors include Yunfu Cui, Yi Xu, Kaiming Leng, Xingming Jiang, Zhenglong Li, Lining Huang, Xiangyu Zhong, Jinglin Li, Yue Yao and Pengcheng Kang and has published in prestigious journals such as International Journal of Molecular Sciences, Gene and Cell Death and Disease.

In The Last Decade

Daolin Ji

18 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daolin Ji China 13 458 452 129 51 30 19 554
Yidong Cheng China 13 330 0.7× 409 0.9× 122 0.9× 35 0.7× 51 1.7× 24 539
Yue Yao China 17 687 1.5× 711 1.6× 181 1.4× 50 1.0× 26 0.9× 25 848
Lining Huang China 15 493 1.1× 447 1.0× 161 1.2× 49 1.0× 16 0.5× 19 576
Pengcheng Kang China 17 561 1.2× 575 1.3× 287 2.2× 99 1.9× 36 1.2× 36 764
Yuting Zhuang China 9 224 0.5× 336 0.7× 66 0.5× 31 0.6× 27 0.9× 10 450
Bing Zhou China 11 421 0.9× 502 1.1× 48 0.4× 40 0.8× 20 0.7× 18 632
Jian Fang Li China 8 361 0.8× 435 1.0× 53 0.4× 142 2.8× 41 1.4× 8 568
Yong Jin China 8 312 0.7× 412 0.9× 49 0.4× 22 0.4× 14 0.5× 12 535

Countries citing papers authored by Daolin Ji

Since Specialization
Citations

This map shows the geographic impact of Daolin Ji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daolin Ji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daolin Ji more than expected).

Fields of papers citing papers by Daolin Ji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daolin Ji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daolin Ji. The network helps show where Daolin Ji may publish in the future.

Co-authorship network of co-authors of Daolin Ji

This figure shows the co-authorship network connecting the top 25 collaborators of Daolin Ji. A scholar is included among the top collaborators of Daolin Ji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daolin Ji. Daolin Ji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Yang, Jing, Xing Luo, Yi Xu, et al.. (2023). Solanum nigrum Linn.: Advances in anti-cancer activity and mechanism in digestive system tumors. Medical Oncology. 40(11). 311–311. 12 indexed citations
3.
4.
Zheng, Wangyang, Yongxu Zhou, Yu Liang, et al.. (2022). Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer. Aging. 14(10). 4425–4444. 6 indexed citations
5.
Zheng, Wangyang, Yuling Zheng, Yongxu Zhou, et al.. (2022). RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma. Journal of Oncology. 2022. 1–17. 6 indexed citations
6.
Zheng, Wangyang, Daolin Ji, Yongxu Zhou, et al.. (2021). Exosomal Noncoding RNAs in Hepatobiliary Cancer: A Rising Star. Molecular Cancer Therapeutics. 20(10). 1777–1788. 3 indexed citations
7.
Ji, Daolin, Peng Huang, Yue Yao, et al.. (2020). <p>Huaier Restrains Cholangiocarcinoma Progression in vitro and in vivo Through Modulating lncRNA TP73-AS1 and Inducing Oxidative Stress</p>. OncoTargets and Therapy. Volume 13. 7819–7837. 16 indexed citations
8.
Li, Jinglin, Xingming Jiang, Zhenglong Li, et al.. (2020). SP1-induced HOXD-AS1 promotes malignant progression of cholangiocarcinoma by regulating miR-520c-3p/MYCN. Aging. 12(16). 16304–16325. 20 indexed citations
9.
10.
Leng, Kaiming, Yi Xu, Pengcheng Kang, et al.. (2019). Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway. Cell Death and Disease. 10(4). 262–262. 31 indexed citations
11.
Huang, Lining, Xingming Jiang, Pengcheng Kang, et al.. (2019). <p>Long non-coding RNA NNT-AS1 functions as an oncogenic gene through modulating miR-485/BCL9 in cholangiocarcinoma</p>. Cancer Management and Research. Volume 11. 7739–7749. 19 indexed citations
12.
Li, Zhenglong, Xingming Jiang, Lining Huang, et al.. (2019). Up‐regulation of ZFAS1 indicates dismal prognosis for cholangiocarcinoma and promotes proliferation and metastasis by modulating USF1 via miR‐296‐5p. Journal of Cellular and Molecular Medicine. 23(12). 8258–8268. 18 indexed citations
13.
Ji, Daolin, Xiangyu Zhong, Xingming Jiang, et al.. (2018). The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Pathology - Research and Practice. 214(10). 1524–1531. 51 indexed citations
14.
Xu, Yi, Yue Yao, Xingming Jiang, et al.. (2018). SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research. 37(1). 81–81. 123 indexed citations
15.
Xu, Yi, Yue Yao, Kaiming Leng, et al.. (2018). Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway. Cellular Physiology and Biochemistry. 51(4). 1710–1722. 70 indexed citations
16.
Zheng, Wangyang, Daolin Ji, Yi Xu, et al.. (2017). NcRNAs and Cholangiocarcinoma. Journal of Cancer. 9(1). 100–107. 18 indexed citations
17.
Li, Zhenglong, Jinglin Li, Daolin Ji, et al.. (2017). Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion. Gene. 645. 131–136. 28 indexed citations
18.
Li, Jinglin, Zhenglong Li, Kaiming Leng, et al.. (2017). ZEB1‐AS1: A crucial cancer‐related long non‐coding RNA. Cell Proliferation. 51(1). 57 indexed citations
19.
Li, Chunlong, Sheng Tai, Xiangyu Zhong, et al.. (2014). GPC1 Regulated by miR-96-5p, Rather than miR-182-5p, in Inhibition of Pancreatic Carcinoma Cell Proliferation. International Journal of Molecular Sciences. 15(4). 6314–6327. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yidong Cheng Breakdown of academic impact, for papers by Yue Yao Breakdown of academic impact, for papers by Lining Huang Breakdown of academic impact, for papers by Pengcheng Kang Breakdown of academic impact, for papers by Yuting Zhuang Breakdown of academic impact, for papers by Bing Zhou Breakdown of academic impact, for papers by Jian Fang Li Breakdown of academic impact, for papers by Yong Jin
Rankless by CCL
2026